Sanofi (France) (SAN.PA) Shifts Focus To Embrace Integration In Diabetes, Unveils Company's Ambition At Conference
6/18/2014 6:44:28 AM
The company has become a leader in the area over the past decade thanks to its insulin Lantus, but now Sanofi wants to move away from the idea of pushing drugs to developing a more integrated diabetes business led by collaboration.
Speaking at a press conference at the event, Sanofi's Pascale Witz, executive VP, global divisions and strategic development, explained that the company was keen to match its efforts in patient care to that of its R&D business, which has moved from an internal model to one that is now reliant on external partners to discover innovative products.
Help employers find you! Check out all the jobs and post your resume.
comments powered by